Publications by authors named "Katri Selander"

Claim this Profile
I
Increased primary breast tumor expression of CD73 is associated with development of bone metastases and is a potential biomarker for adjuvant bisphosphonate use.
Nataliia Petruk, Steven L Wood, Walter Gregory, Ana Lopez-Guajardo, Maria Oliva, Katri S Selander

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased PD-1 expression in livers associated with PD-1-antibody-induced hepatotoxicity.
Miro Saarela, Essi Parviainen, Ana Lleo, Luca di Tommaso, Hanna Raunio, Katri S Selander

BMC Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human papillomavirus E6 alters Toll-like receptor 9 transcripts and chemotherapy responses in breast cancer cells in vitro.
Essi Parviainen, Sini Nurmenniemi, Sara Ravaioli, Sara Bravaccini, Aki Manninen, Katri Selander

Mol Biol Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study design for DESTINY-Breast Respond HER2-low Europe: T-DXd in patients with HER2-low advanced breast cancer.
Valentina Guarneri, José Luís Passos Coelho, Francois P Duhoux, Daniel Egle, José Ángel García-Sáenz, Katri Selander

Future Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposome-encapsulated zoledronate increases inflammatory macrophage population in TNBC tumours.
Nataliia Petruk, Sofia Sousa, Martine Croset, Lauri Polari, Hristo Zlatev, Katri Selander

Eur J Pharm Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD73 regulates zoledronate-induced lymphocyte infiltration in triple-negative breast cancer tumors and lung metastases.
Nataliia Petruk, Arafat Siddiqui, Sina Tadayon, Jorma Määttä, Pieta K Mattila, Katri S Selander

Front Immunol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas.
Peeter Karihtala, Katja Porvari, Nelli Roininen, Sari Voutilainen, Johanna Mattson, Katri Selander

Oncogenesis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer.
Nataliia Petruk, Sanni Tuominen, Malin Åkerfelt, Jesse Mattsson, Jouko Sandholm, Katri S Selander

Sci Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and evaluation of nNa1.5 sodium channel blockers with potent cell invasion inhibitory activity in breast cancer cells.
Shilpa Dutta, Osbaldo Lopez Charcas, Samuel Tanner, Frédéric Gradek, Virginie Driffort, Katri Selander

Bioorg Med Chem· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
Madison R Chandler, Kimberly S Keene, Johanna M Tuomela, Andres Forero-Torres, Renee Desmond, Katri S Selander

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma.
Muhammad Omer Jamil, Mary S Jerome, Deborah Miley, Katri S Selander, Francisco Robert

Lung Cancer (Auckl)· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo.
Jouko Sandholm, Jaakko Lehtimäki, Tamiko Ishizu, Sadanandan E Velu, Jeremy Clark, Katri S Selander

Oncotarget· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telomeric G-quadruplex-forming DNA fragments induce TLR9-mediated and LL-37-regulated invasion in breast cancer cells in vitro.
Johanna M Tuomela, Jouko A Sandholm, Mika Kaakinen, Katherine L Hayden, Kirsi-Maria Haapasaari, Katri S Selander

Breast Cancer Res Treat· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
Joonas H Kauppila, Johanna Korvala, Kristiina Siirilä, Marika Manni, Laura K Mäkinen, Katri S Selander

J Oral Pathol Med· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor infiltrating CD8 T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma.
Mikko Mella, Joonas H Kauppila, Peeter Karihtala, Petri Lehenkari, Arja Jukkola-Vuorinen, Katri S Selander

Oncoimmunology· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor 9 in breast cancer.
Jouko Sandholm, Katri S Selander

Front Immunol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia regulates Toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro.
Jouko Sandholm, Johanna Tuomela, Joonas H Kauppila, Kevin W Harris, David Graves, Katri S Selander

Oncol Lett· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptors in esophageal cancer.
Joonas H Kauppila, Katri S Selander

Front Immunol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells.
Johanna Tuomela, Jouko Sandholm, Mika Kaakinen, Ankita Patel, Joonas H Kauppila, Katri S Selander

Breast Cancer Res Treat· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer.
Johanna Tuomela, Jouko Sandholm, Joonas H Kauppila, Petri Lehenkari, Kevin W Harris, Katri S Selander

Oncol Lett· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion.
Joonas H Kauppila, Tuomo J Karttunen, Juha Saarnio, Pia Nyberg, Tuula Salo, Katri S Selander

APMIS· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer.
Marja-Riitta Väisänen, Arja Jukkola-Vuorinen, Katri S Vuopala, Katri S Selander, Markku H Vaarala

Oncol Lett· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer.
Johanna Tuomela, Jouko Sandholm, Peeter Karihtala, Joanna Ilvesaro, Katri S Vuopala, Katri S Selander

Breast Cancer Res Treat· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma.
Joonas H Kauppila, Heikki Takala, Katri S Selander, Petri P Lehenkari, Juha Saarnio

Histopathology· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma.
Hanna Ronkainen, Pasi Hirvikoski, Saila Kauppila, Katri S Vuopala, Timo K Paavonen, Katri S Selander

J Exp Clin Cancer Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis